Morgan Stanley’s enVVeno Medical NVNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
75,337
+9,373
| +14% | +$37.4K | ﹤0.01% | 5688 |
|
|
2025
Q1 | $173K | Sell |
65,964
-60,968
| -48% | -$160K | ﹤0.01% | 5791 |
|
|
2024
Q4 | $383K | Sell |
126,932
-7,200
| -5% | -$21.7K | ﹤0.01% | 5532 |
|
|
2024
Q3 | $451K | Buy |
134,132
+39,259
| +41% | +$132K | ﹤0.01% | 5452 |
|
|
2024
Q2 | $498K | Sell |
94,873
-2,677
| -3% | -$14.1K | ﹤0.01% | 5294 |
|
|
2024
Q1 | $531K | Sell |
97,550
-23,540
| -19% | -$128K | ﹤0.01% | 5284 |
|
|
2023
Q4 | $622K | Buy |
121,090
+77,776
| +180% | +$400K | ﹤0.01% | 5531 |
|
|
2023
Q3 | $233K | Buy |
43,314
+6,328
| +17% | +$34.1K | ﹤0.01% | 5511 |
|
|
2023
Q2 | $114K | Buy |
36,986
+8,082
| +28% | +$24.9K | ﹤0.01% | 5891 |
|
|
2023
Q1 | $135K | Sell |
28,904
-1,526
| -5% | -$7.14K | ﹤0.01% | 5885 |
|
|
2022
Q4 | $155K | Sell |
30,430
-1,855
| -6% | -$9.46K | ﹤0.01% | 5772 |
|
|
2022
Q3 | $203K | Buy |
32,285
+4,005
| +14% | +$25.2K | ﹤0.01% | 5721 |
|
|
2022
Q2 | $107K | Sell |
28,280
-7,674
| -21% | -$29K | ﹤0.01% | 6235 |
|
|
2022
Q1 | $230K | Sell |
35,954
-20,776
| -37% | -$133K | ﹤0.01% | 5844 |
|
|
2021
Q4 | $374K | Sell |
56,730
-114,814
| -67% | -$757K | ﹤0.01% | 5719 |
|
|
2021
Q3 | $1.78M | Buy |
+171,544
| New | +$1.78M | ﹤0.01% | 4661 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 6667 |
|
|
2018
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6679 |
|